Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep286 | Calcium and Vitamin D metabolism | ECE2015

Thalassemia-induced osteoporosis and bisphosphonate treatment: a systematic review and meta-analysis

Tsartsalis Athanasios , Lambrou George , Savvidis Christos , Chrousos George , Kattamis Antonis

Introduction: Osteopenia and osteoporosis develop with aging in thalassemia patients despite clinical treatment therapy has improved. Bisphosphonates, which are potent inhibitors of osteoclastic bone resorption, have been recently used to correct the bone abnormality in thalassemia with encouraging results. Bisphosphonates are a class of drugs that prevent the loss of bone mass, used to treat osteoporosis and similar diseases. They are the most commonly prescribed drugs used t...

ea0063p366 | Thyroid 1 | ECE2019

Ocular cavity metastasis from poorly differentiated thyroid carcinoma

Belis Constantinos , Gavriilidou Stavroula , Afentoulidi Aikaterini , Xydiari Kalliopi , Athanasiou Vasileios , Malaktari-Skarantavou Sofia , Savvidis Christos

Introduction: Poorly differentiated thyroid carcinoma is a tumor of follicular origin with morphological and biological characteristics between anaplastic and well differentiated carcinoma. It accounts for less than 5% of all thyroid tumors and is characterized by adverse prognosis, aggressive behavior and frequently distant metastases, mainly to lungs and bones and to a lesser extent to brain, liver, kidney, breast and skin. Incident presentation: We report a case of a patien...

ea0037ep16 | Adrenal cortex | ECE2015

Adrenal malignant melanoma masquerading as a phaeochromocytoma

Barmpari Maria , Savvidis Christos , Dede Anastasia , Markogiannakis Haridimos , Giannopoulos Dimitrios , Dikoglou Christina , Malaktari-Skarantavou Sofia

Introduction: Adrenal masses usually represent benign and nonfunctional adrenal adenomas however, primary or metastatic malignancy should also be considered. Discovery of an adrenal mass needs further evaluation in order to exclude malignancy and hormonal secretion. Primary adrenal melanoma is an extremely rare entity, while metastases of cutaneous melanoma to the adrenals occur much more often. We present a rare case of a possibly primary adrenal malignant melanoma with imagi...

ea0049ep859 | Clinical case reports - Pituitary/Adrenal | ECE2017

Hypopituitarism caused by an intrasellar meningioma: case report

Gavriilidou Stavroula , Belis Constantinos , Xydiari Kalliopi , Afentoulidi Aikaterini , Athanasiou Vasilios , Malaktari-Skarantavou Sofia , Tournis Symeon , Savvidis Christos

Meningioma is a common, usually benign, tumor of the brain and the spinal cord that originates from any dura surface. Such lesion accounts for 10 to 15% of nonadenomatous sellar masses. Purely intrasellar meningiomas are relatively rare and can mimic a nonfunctioning adenoma. A 33-year-old man with a history of 1.5 year fatigue, anemia and erectile dysfunction referred to our department. The laboratory data revealed low levels of ACTH, Cortisol, FSH, LH and Testosterone, while...

ea0049ep1202 | Clinical case reports - Thyroid/Others | ECE2017

Follicular variant of papillary thyroid carcinoma with lung, bone, and soft tissue metastases

Belis Constantinos , Gavriilidou Stavroula , Afentoulidi Aikaterini , Xydiari Kalliopi , Athanasiou Vasilios , Malaktari- Skarantavou Sofia , Saranti Sofia , Savvidis Christos

We report on a case of a 63-year-old male patient with a history of metastatic DTC, with both lung and bone metastases and an additional paravertebral mass. The patient presented with enlargement of the left thyroid lobe. FNA was positive for malignancy and subsequent CTs were negative for distant metastases, whereas laboratory tests showed elevated thyroglobulin (Tg>500 ng/ml). The patient underwent total thyroidectomy and the pathology report revealed a multifocal, folli...

ea0063p367 | Thyroid 1 | ECE2019

Giant cystic pheochromocytoma: A clinically silent entity

Afentoulidi Aikaterini , Markogiannakis Haridimos , Kekis Panagiotis , Natoudi Maria , Gavriilidou Stavroula , Belis Constantinos , Xydiari Kalliopi , Athanasiou Vasileios , Malaktari-Skarantavou Sofia , Leandros Emmanouil , Savvidis Christos

Introduction: Pheochromocytomas (PCCs) are rare neuroendocrine catecholamine secreting-tumors derived from chromaffin cells of the adrenal medulla. PCCs are usually solid tumors but rarely occur as a cystic lesion. Cystic pheocromocytomas (CPCCs) are usually asymptomatic, unilateral and of a large size without typical radiological and biochemical features of pheochromocytomas. Non-specific abdominal pain has been reported in several cases.Case Presentati...

ea0063p401 | Thyroid 1 | ECE2019

Jejunum metastasis and perforation from anaplastic thyroid cancer

Gavriilidou Stavroula , Belis Constantinos , Afentoulidi Aikaterini , Xydiari Kalliopi , Fotou Maria , Oikonomou Vassiliki , Zoumpouli Christina , Stroumpouli Evangelia , Athanasiou Vasileios , Malaktari-Skarantavou Sofia , Savvidis Christos

Introduction: Anaplastic thyroid carcinoma (ATC) accounts for 1.7% of all thyroid cancers with poor prognosis and a median survival of 4 to 12 months. We report a case of ATC with small intestine perforation due to metastasis in the jejunum.Case report: A 57-year-old woman was referred to our department for a rapidly enlarging goiter and dyspnea. Her latest thyroid ultrasound was performed about a month ago and demonstrated 2 nodules measuring 21×16...

ea0063p833 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

The role of somatostatin analogs in the control of carcinoid syndrome: systematic review and meta-analysis

Alexandraki Krystallenia , Angelousi Anna , Chatzellis Eleftherios , Chrisoulidou Alexandra , Kalogeris Nikolaos , Kanakis Georgios , Savvidis Christos , Vassiliadi Dimitra , Toulis Konstantinos , Tsagarakis Stylianos , Kaltsas Gregory

Introduction: Somatostatin analogues (SSAs) are the mainstay of treatment for carcinoid syndrome (CS)-related symptoms. Controversy still exists regarding the extent of the efficacy of this intervention. The purpose of the systematic review and meta-analysis was to evaluate the percentage of patients achieving partial (PR) or complete response (CR) with the use of SSAs (lanreotide, octreotide, pasireotide) in patients with CS. Due to lack of uniformity and established criteria...